And here it is: the new The EBMT handbook

Everything about transplant and cellular therapies

For everyone everywhere

Because it is FREE🎉 #EBMT24

Kudos to all contributors including The EBMT_Trainee

👇
link.springer.com/book/10.1007/9…

A truly outstanding talk about inflammation & immune modulation in #MDSsm by Kordasti_lab in #ESHMDS2024 ESH (Haematology)

🎉We will celebrate the 50th birthday of The European Society for Blood and Marrow Transplantation (The EBMT) from this weekend on at #EBMT24 in Glasgow🏴󠁧󠁢󠁳󠁣󠁴󠁿🎉

What it is and does... a short 🧵for everyone

The EBMT_Trainee

Over the next three days, leading experts will present updates and insights in the field of MDS at #ESHMDS2024 ! 🩸

Stay tuned for our exclusive virtual interviews on VJHemOnc.com, coming soon! 👀

#MDSsm ESH (Haematology) #HemOnc

Bruno Paiva Mayo Clinic Dana-Farber U.S. FDA Now updating: the 4/12/24 ODAC meeting on MRD testing as an early endpoint in myeloma clinical trials from International Myeloma Foundation. Sharing with Noopur Raje, Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰, Tom Martin, Ajai Chari, & Shaji Kumar the news as it develops.

I started the EVIDENCE meta-analysis in 2009. After 15 yrs of work, I will present 4/12 at ODAC: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patients’ access to new drugs?

#mmsm ⁦Multiple Myeloma RF⁩ ⁦International Myeloma Foundation⁩ youtube.com/live/pooME9gMa…

Only 3️⃣ days left for #EBMT24 - Europe’s largest annual congress in blood and marrow transplantation and cellular therapies! Come celebrate with us the 50th Annual Meeting of the EBMT between April 14-17! 🎉

Safe travels to Glasgow! 🚅✈️Glasgow Convention Bureau

In just over two weeks, we will be attending #BSH2024 and bringing you exclusive coverage of the meeting over on VJHemOnc.com! 🙌

We can’t wait to hear the latest updates from leading experts in the field!🩸

BSH - Haematology #HemOnc #Hematology

Great to see this out in print in Blood Advances ! 🎉🥳

Check out our study examining the clinical impact of the new European Hematology Association The EBMT grading of immune effector cell-associated hematotoxicity in a cohort of ~550 CAR T cell patients ⤵️

ashpublications.org/bloodadvances/…

⭐The 10th COMy Congress⭐️

EXTENDED call for your abstract!
🔽🔽
bit.ly/3XqEQN3

Register TODAY and save your spot 👇
bit.ly/3ZSb31v

📅 May 23-26, 2024
🗼 Paris, France & Online

Mohamad Mohty Arnon Nagler marivi mateos

Susan Bal, discusses using #MRD to understand the response to #autoSCT in patients with #multiplemyeloma 🩸 🎥 👉 ow.ly/6T6e50R43z7

Interested in MRD in Myeloma? Join us for the Miami #Myeloma #MRD 2024 Virtual Workshop 📣

Register for FREE 👉 ow.ly/A7Ke50R43z8

Want to learn more about novel therapies in SMM, non-drug interventions, ongoing trials in the field, and more?

Explore our roundtables from #IBC2024 below:

👉ow.ly/TLWj50R36gC

ft. Omar Nadeem, Urvi Shah, Bruno Paiva, Kwee Yong, Irene Ghobrial & more!

#MMsm

Tune in for CLL/SLL diagnosis, prognosis, and treatment.
#hemepath #lymsm
Thanks Matthew Davids, MD, MMSc

Last week, the FDA approved cilta-cel for patients with R/R myeloma after at least one prior line of therapy - what an exciting time in the #MMsm treatment landscape!

Read more about this in our feature article 📖 below:

👉 ow.ly/4s9L50Rco58

#CARTcell #ImmunoOnc #Hemonc

We're excited to share our recent CLL heme-path case study ft. Sanam Loghavi, MD صنم لغوی 🔬🧬 & Matthew Davids, MD, MMSc, who explore:

✔️ Disease diagnosis & prognostication in CLL
✔️ The importance of genetic testing & immunophenotyping in clinical decision-making

👉 ow.ly/z8yc50R89HS

#CLLsm #LeuSM

Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK British Journal of Haematology #DLBCL #CART

British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/full/10.11…

The one-week countdown is on until the upcoming 50th Annual Meeting of the EBMT in Glasgow!

Don’t miss out on our exclusive interviews with leading experts.

The EBMT #MPNsm #MDSsm #AMLsm #CLLsm #EBMT24

Our 50th Annual Meeting is only a few days away! 📅✨ #EBMT24

Register now to attend in-person in Glasgow 📍 or virtually 🌐 and receive access to all the content for 2 months after the event.

Join the congress ➡️ ebmt.org/annual-meeting…

#MedTwitter #BMT #Celltherapy

Fireside chat with Dr Gormley (FDA) & C. Ola Landgren, M.D.: 'What is happening in MRD in myeloma, what is next?'

- Patient perspectives on MRD, Yelak Biru & Dr Mikhael (IMF)

- Perspectives on MRD assays, Dr Mulligan (MMRF)

-MRD in the real world, Jennifer Ahlstrom (HealthTree)

5/5

SESSION III:
- Updates on MASTER treatment cessation study, Dr Costa
- Updates on UChicago treatment cessation study, Dr Derman
- Updates on MSKCC treatment cessation study, Dr Korde
- Updates on UK Myeloma XI trial; (when) can you stop maintenance therapy? Dr Pawlyn

4/X